Previous Close | 0.3900 |
Open | 0.4200 |
Bid | 0.3200 |
Ask | 0.3600 |
Strike | 90.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.3500 - 0.4200 |
Contract Range | N/A |
Volume | |
Open Interest | 2.34k |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call